New York Stock Exchange
New York, NY
Wilson Sonsini is proud to sponsor the NewYorkBIO Life Science Company Showcase and Reception on December 15, 2025 at the NYSE. Partner David Sharon will join industry leaders from 2:40 PM - 3:25 PM ET for the panel titled "IPO, M&A, or Alternative Pathways: Navigating the Next Exit Cycle." Panelists will explore routes to liquidity and market readiness for emerging companies. For more information please visit the Showcase website and the Reception website.
Madelaine Holden
mholden@wsgr.com
David Sharon is a partner in Wilson Sonsini Goodrich & Rosati’s New York office, where he focuses on corporate and securities work for both public and private companies across all stages of growth. David’s broad capital markets experience includes initial public, follow-on, and secondary equity offerings; investment grade, high-yield, and convertible debt offerings; and private investment in public equity (PIPE) transactions.